A complete application in a minute — tailored resume and cover letter, ready to send.
BioAge Labs is seeking a scientist/engineer to design and deploy AI systems for translational science, grounding every claim in retrievable evidence and published precedent. You will own end-to-end engineering—from retrieval and orchestration to evaluation and deployment—and work with target biology teams to ensure scientifically sound recommendations.
This production-grade role emphasizes building AI workflows, handling multi-modal data, and delivering decision-grade outputs that support drug
BioAge Labs (BIOA) is finding new ways to treat disease by targeting the mechanisms of aging, with the ultimate goal of increasing healthy human lifespan. https://bioagelabs.com
We are seeking a scientist/engineer with hands‑on expertise in building generative and agentic AI systems and a strong foundation in target discovery, drug discovery and translational science. You will design and deploy AI‑enabled systems that take a target and produce decision‑grade, evidence‑backed recommendations — from mechanism hypotheses to validation design — with every claim grounded in retrievable evidence and every gap stated explicitly, and that assess how likely a human‑derived signal is to hold up in the lab and beyond.
This role is ideal for someone who would rather build production AI systems for translational science than only run analyses, and who has enough hands‑on biology to know when a recommendation is scientifically sound and when it merely reads well. You will own the engineering of these systems end to end, from retrieval and orchestration to evaluation and deployment, and work as a peer with the scientists who act on their outputs.
Preferred technical qualifications
Preferred scientific qualifications
Also valued
Our company
BioAge is a clinical‑stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The Company's lead product candidate, BGE‑102, is a potent, orally available, brain‑penetrant small‑molecule NLRP3 inhibitor being developed for cardiovascular risk and retinal diseases including diabetic macular edema. BGE‑102 has completed a Phase 1 SAD/MAD trial demonstrating a well‑tolerated profile and potential best‑in‑class reductions in hsCRP and other inflammatory biomarkers in participants with obesity and elevated inflammation. Phase 2 cardiovascular risk proof‑of‑concept data are anticipated in H2 2026, and Phase 1b/2a diabetic macular edema proof‑of‑concept data are anticipated in mid 2027. The Company is also developing long‑acting injectable and oral small molecule APJ agonists for obesity. BioAge’s additional preclinical programs, which leverage insights from the Company’s proprietary discovery platform built on human longevity data, address key pathways involved in metabolic aging. BioAge has been listed on Nasdaq (BIOA) since 2024. For additional information about BioAge, visit the company’s website at https://bioagelabs.com.
BioAge offers competitive salary, a comprehensive compensation package, and generous paid time off in addition to company‑observed holidays. We provide comprehensive health and wellness benefits (medical, dental, and vision insurance) and a 401(k) retirement savings plan with matching employer contributions, and we support families through childcare and fertility benefits. We also pride ourselves in giving employees many opportunities for career development, including a generous annual budget for continued learning and a dedication to training and skill development. Many positions (including this one) are remote, allowing our team members to work from anywhere. The salary for this role is expected to be approximately $150,000 - $185,000, depending on experience. We are open to the concept that different experience levels add value to the team in different ways, and therefore will consider a variety of experience and offer commensurate pay.
At BioAge, we embrace diversity and differences while we learn from each other, and we believe that every team member has an important role to play. We are an equal opportunity employer. BioAge prohibits discrimination and harassment of any type and affords equal employment opportunities to employees and applicants without regard to race, color, religion, sex, national origin, disability status, protected veteran status, or any other characteristic protected by law. BioAge conforms to the spirit as well as to the letter of all applicable laws and regulations.